secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2025-02-03T23:59:59+00:00
Accession:  0001193125-25-018849
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor: preliminary Q4 net loss ~$300M, $310M goodwill impairment; launches financing for Rotech acquisition
--------------------------------------------------------------------------------

- Q4 prelim rev $2.67-2.70B; net loss $(288-311)M; adj EBITDA $135-140M; adj EPS $0.52-0.55.
- FY2024 prelim rev $10.67-10.70B; net loss $(355-378)M; adj EBITDA $520-525M; adj EPS $1.50-1.53.
- Non-cash goodwill impairment ~$310M in Apria division from stock decline, rates, contract pricing.
- Total debt reduced by over $240M in 2024; total debt ~$1.854-1.859B; net debt ~$1.805-1.810B.
- Commenced financing for previously announced Rotech acquisition; expected close 1H 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000119312525018849/0001193125-25-018849-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000119312525018849/d872714d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-018849

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer